A Phase 1 Study of MM-111; A Bispecific HER2/HER3 Antibody...

Annals of Oncology 2012 / 09 Vol. 23

A Phase 1 Study of MM-111; A Bispecific HER2/HER3 Antibody Fusion Protein, Combined with Multiple Treatment Regimens in Patients with Advanced HER2 Positive Solid Tumors

Richards, D., Braiteh, F., Anthony, S., Edenfield, W., Hellerstedt, B., Raju, R., Conkling, P., McDonagh, C., Frye, S., Moyo, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/S0923-7534(20)33058-1
Date:
September, 2012
File:
PDF, 62 KB
2012
Conversion to is in progress
Conversion to is failed